Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals

Microbiology Spectrum(2023)10.1128/spectrum.04081-22Source: DataRank Database

Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals is a research paper published in Microbiology Spectrum (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.71)OA: goldTopics (57)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Yen-Chia Lin,Lauren L. Ching ORCID,Jih‐Jin Tsai ORCID,Kyle Ishikawa ORCID,Wen-Yang Tsai ORCID

Live enrichment

PubMed:37428104 OpenAlex:https://openalex.org/W4383710565

City and County of Honolulu

Grant: CT-MAY-2000282

CU | National Cancer Institute, Cairo University

Grant: U54MD007601

Hawaii Community Foundation

Grant: MedRes-2022-0000 0789

MOHW | Health Promotion Administration, Ministry of Health and Welfare

Grant: MOHW109-TDU-B-212-114006

MOHW | Health Promotion Administration, Ministry of Health and Welfare

Grant: MOHW109-TDU-B-212-124006

National Health Research Institutes

Grant: NHRI-110A1-MRCO-03212101

National Institutes of Health

Grant: 5P30GM114737-05

Pacific Center for Emerging Infectious Diseases Research

National Institutes of Health

Grant: 2U54MD007601-31

Ola HAWAII

NIGMS NIH HHS

Grant: P20 GM103466

NIGMS NIH HHS

Grant: P30 GM114737

FWCI

0.71

Citation Percentile

0.7%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://journals.asm.org/doi/pdf/10.1128/spectrum.04081-22?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.04081-22?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.04081-22

journalhttp://dx.doi.org/10.1128/spectrum.04081-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37428104

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingVaccine Coverage and Hesitancy0303 health sciences03 medical and health sciencesVaccinationAntibodies, ViralCOVID-19COVID-19 VaccinesImmunization, SecondarySARS-CoV-2HumansHalf-LifeAntibodies, NeutralizingCOVID-19 vaccine booster shotSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAntibodies, ViralHalf-LifeHumansImmunization, SecondaryVaccinationAntibodies, Neutralizing

Keywords

NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)Pandemic2019-20 coronavirus outbreakBooster (rocketry)TiterBooster doseBiologyImmunologyVirusMedicineOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Vaccineshalf-lifeSARS-CoV-2VaccinationImmunization, SecondaryCOVID-19variants of concernAntibodies, ViralMicrobiologyAntibodies, NeutralizingQR1-502mRNA vaccineHumansneutralizing antibodiessevere acute respiratory syndrome coronavirus 2Research Article

Sustainable Development Goals

SDG 0: Good health and well-being